Anti-TNF-alpha therapy for acute rejection in intestinal transplantation.
暂无分享，去创建一个
[1] H. Volk,et al. Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation , 2003, Transplantation.
[2] W Domschke,et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. , 2001, Gastroenterology.
[3] G. Kobbe,et al. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody , 2001, Bone Marrow Transplantation.